Methinks utilizes AI algorithms to analyze non-contrast CT scans for the rapid detection of Large Vessel Occlusions and hemorrhages, facilitating timely decision-making in stroke treatment. By integrating with Microsoft Teams, the platform enhances stroke coordination, ensuring that medical teams receive critical imaging results promptly, which is essential for effective patient care.
Funding
$9.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Delays in stroke diagnosis and treatment, particularly in identifying Large Vessel Occlusions (LVOs) and hemorrhages, can lead to poor patient outcomes. Traditional diagnostic methods often require specialized equipment and trained personnel, limiting accessibility and speed of diagnosis, especially in hospitals with limited resources.
Solution
Methinks offers an AI-powered platform that analyzes non-contrast CT (NCCT) scans to rapidly detect LVOs and hemorrhages, enabling faster decision-making in stroke management. The platform integrates with Microsoft Teams to facilitate stroke team coordination by delivering critical imaging results directly to clinicians. By leveraging AI on widely available NCCT scans, Methinks aims to make timely stroke treatment accessible to every patient, regardless of location or hospital resources. The AI algorithms provide high sensitivity and specificity in identifying LVOs and hemorrhages, ensuring stroke teams receive timely, critical information for life-saving decisions.
Target Audience
The primary target audience includes neurologists, radiologists, stroke specialists, and hospital networks seeking to improve stroke diagnosis and treatment workflows.
Features
- AI-driven analysis of non-contrast CT scans for rapid detection of Large Vessel Occlusions (LVO) and hemorrhages.
- Seamless integration with Microsoft Teams for real-time communication and results delivery.
- High sensitivity (87.2% for LVO, 97.3% for ICH) and specificity (87.7% for LVO, 99.4% for ICH) in detecting critical stroke indicators.
- Advanced image viewing tools for detailed review of patient scans.
- Secure platform adhering to the highest security standards for patient data protection.